H.R.3537 - Dangerous Synthetic Drug Control Act of 2016114th Congress (2015-2016)
|Sponsor:||Rep. Dent, Charles W. [R-PA-15] (Introduced 09/17/2015)|
|Committees:||House - Energy and Commerce; Judiciary | Senate - Judiciary|
|Committee Reports:||H. Rept. 114-787|
|Latest Action:||Senate - 09/27/2016 Received in the Senate and Read twice and referred to the Committee on the Judiciary. (All Actions)|
|Roll Call Votes:||There has been 1 roll call vote|
This bill has the status Passed House
Here are the steps for Status of Legislation:
- Passed House
Text: H.R.3537 — 114th Congress (2015-2016)All Information (Except Text)
Text available as:
Referred in Senate (09/27/2016)
Received; read twice and referred to the Committee on the Judiciary
To amend the Controlled Substances Act to add certain synthetic substances to schedule I, and for other purposes.
This Act may be cited as the “Dangerous Synthetic Drug Control Act of 2016”.
(a) Cannabimimetic agents.—Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection (d)(2)(B)—
(1) in clause (xiv) by striking “and” at the end;
(2) in clause (xv) by striking the period and inserting a semicolon; and
(3) by adding at the end the following:
“(xvi) 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (JWH–251);
“(xvii) (1-butyl-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone (4′-methyl JWH–073);
“(xviii) 2-(3-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (JWH–302);
“(xix) N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (5F–APICA);
“(xx) quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5F–PB–22);
“(xxi) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB–PINACA);
“(xxii) N-(naphthalen-1-yl)-1-pentyl-1H-indole-3-carboxamide (MN–24);
“(xxiii) (1-(5-fluoropentyl)-1H-indazol-3-yl)(naphthalen-1-yl)methanone (THJ–2201);
“(xxiv) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADBICA);
“(xxv) methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (5F–AMB); and
“(xxvi) methyl 2-(1-(cyclohexylmethyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (MA–CHMINACA).”.
(b) Synthetic opioids.—Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection (a) by adding at the end the following:
“(43) Butyryl fentanyl.
“(45) Acetyl fentanyl.”.
(c) Other drugs.—Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection (c) by adding at the end the following:
“(29) 1-(naphthalen-1-yl)-2-(pyrrolidin-1-yl)pentan-1-one (α-naphyrone).
“(30) 1-(2,3-dihydrobenzofuran-5-yl)propan-2-amine (5–APDB).
“(31) 1-(2,3-dihydrobenzofuran-6-yl)propan-2-amine (6–APDB).
“(32) 6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-6-amine (MDAI).
“(33) 5-iodo-2,3-dihydro-1H-inden-2-amine (5–IAI).
“(34) 1-(4-bromofuro[2,3-f]benzofuran-8-yl)propan-2-amine (bromo-dragonfly).
“(35) 1-(4-chloro-2,5-dimethoxyphenyl)propan-2-amine (DOC).
“(36) 1-(4-ethoxy-2,5-dimethoxyphenyl)propan-2-amine (MEM).”.
Passed the House of Representatives September 26, 2016.
|Attest:||karen l. haas,|